Popular YouTube creator IShowSpeed is lending his voice — and high-energy personality — to an anime-style series in the works at Brian Robbins‘ Big Shot Pictures production start-up. While plot ...

Winter is finally over, and the night is no longer dark and full of terrors. Instead, it’s full of new anime to watch. Spring has arrived with a wave of returning favorites, new original shows, and ...

Lucas Kloberdanz-Dyck is a writer for Collider. He grew up creating lists, stories, and worlds, which led to his love of anime and video games. He attended Sheridan College where he earned an Honours ...

Anime keeps getting better. From music to animation, the best series reel viewers in and keep them talking about what’s to come. With spring here, despite winter’s refusal to release some states from ...

India’s Almighty Motion Picture, the production company behind “Made in India – A Titan Story,” is moving to bring the business bestseller “Harsh Realities: The Making of Marico” to the screen, ...

Lucas Kloberdanz-Dyck is a writer for Collider. He grew up creating lists, stories, and worlds, which led to his love of anime and video games. He attended Sheridan College where he earned an Honours ...

The Chicago Bears will inevitably have to make some difficult decisions this offseason, especially as the team is currently navigating through negative $4.1 million in available cap space, according ...

Have your lips been chapped and your skin felt extra dry this season? You’re not imagining things. In places like the East and Midwest, it hasn’t just been cold; humidity levels have been unusually ...

EXCLUSIVE: Sketch this date into your calendar: The 10th anniversary Crunchyroll Anime Awards ceremony is set for Saturday, May 23, in Tokyo. Sally Amaki and Jon Kabira are returning as co-hosts for a ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. In 2016, former Pittsburgh Steelers quarterback Terry Bradshaw was asked his thoughts on head coach Mike Tomlin, who ...

Novel therapies for multiple myeloma (MM), including chimeric antigen receptor T-cell and bispecific antibodies, extend lives but raise concerns about treatment costs and adherence, and they haven't ...